NCT02741219View on ClinicalTrials.gov

A Multicenter Study: Dexmedetomidine Combined With Sufentanil for Patient Controlled Intravenous Analgesia After Caesarean Section

PHASE4CompletedINTERVENTIONAL
Enrollment

225

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Postoperative Pain
Interventions
DRUG

Normal saline

Control Group receives normal saline bolus after delivery

DRUG

Dexmedetomidine

Dex Group receives dexmedetomidine bolus 0.5mcg/kg after delivery

DRUG

Sufentanil

sufentanil PCA after surgery

DRUG

Sufentanil and dexmedetomidine

sufentanil combined with dexmedetomidine PCA after surgery

Trial Locations (1)

200090

Obstetrics & Gynecology Hospital of Fudan University, Shanghai

All Listed Sponsors
lead

Obstetrics & Gynecology Hospital of Fudan University

OTHER

NCT02741219 - A Multicenter Study: Dexmedetomidine Combined With Sufentanil for Patient Controlled Intravenous Analgesia After Caesarean Section | Biotech Hunter | Biotech Hunter